Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed with results

Key Signals

2 with results86% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (8)
P 1 (2)
P 3 (1)

Trial Status

Completed6
Active Not Recruiting1
Unknown1
Withdrawn1
Not Yet Recruiting1
Terminated1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (12)

Research Network

Activity Timeline